Dermapharm Holding Se Stock Short Ratio
| DMP Stock | 38.50 0.70 1.85% |
Dermapharm Holding SE fundamentals help investors to digest information that contributes to Dermapharm Holding's financial success or failures. It also enables traders to predict the movement of Dermapharm Stock. The fundamental analysis module provides a way to measure Dermapharm Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dermapharm Holding stock.
Dermapharm |
Dermapharm Holding SE Company Short Ratio Analysis
Dermapharm Holding's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Dermapharm Holding SE has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers-Specialty & Generic (which currently averages 0.0) industry. The short ratio for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Dermapharm Fundamentals
| Return On Equity | 0.38 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 2.68 B | |||
| Shares Outstanding | 53.84 M | |||
| Shares Owned By Insiders | 65.04 % | |||
| Shares Owned By Institutions | 17.12 % | |||
| Price To Book | 4.69 X | |||
| Price To Sales | 2.04 X | |||
| Revenue | 942.91 M | |||
| Gross Profit | 610.22 M | |||
| EBITDA | 357.65 M | |||
| Net Income | 209.58 M | |||
| Cash And Equivalents | 161.38 M | |||
| Total Debt | 574.72 M | |||
| Book Value Per Share | 9.36 X | |||
| Cash Flow From Operations | 250.37 M | |||
| Earnings Per Share | 3.32 X | |||
| Target Price | 56.3 | |||
| Number Of Employees | 2.37 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 2.1 B | |||
| Total Asset | 1.41 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 1.41 B | |||
| Last Dividend Paid | 2.17 |
About Dermapharm Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dermapharm Holding SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dermapharm Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dermapharm Holding SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dermapharm Stock Analysis
When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.